Arthritis Research & Therapy

official impact factor 4.36
Search for
Advanced search
Arthritis Research & Therapy
Tools
Share this article
Open Access Highly Access

Initial clinical trial of epratuzumab (humanized anti-CD22 antibody) for immunotherapy of systemic lupus erythematosus

Thomas Dörner*, Joerg Kaufmann, William A Wegener, Nick Teoh, David M Goldenberg and Gerd R Burmester

Arthritis Research & Therapy 2006, 8:R74 doi:10.1186/ar1942


See related commentary by Eisenberg: http://arthritis-research.com/content/8/3/108

Accesses  

  • Last 30 days: 182 accesses
  • Last 365 days: 1650 accesses
  • All time: 10473 accesses

Cited by

BioMed Central: 9 citations

Google Scholar: View citations

ISI Web of Science: View citations

PubMed Central: View citations